Kajanti M, Karkinen-Jääskeläinen M, Rissanen P
Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Finland.
Acta Oncol. 1988;27(1):51-5. doi: 10.3109/02841868809090318.
A retrospective study was made of 36 patients with primary gastrointestinal (GI) non-Hodgkin lymphoma (NHL), of which 16 occurred in stomach, 14 in small intestine, 3 in ileocecal region and 3 in large intestine. The mean age was 57 years. According to the 'Working Formulation' large cell lymphomas were most common. All patients were surgically explored, 27 undergoing resection and 9 laparotomy with biopsy. Radiotherapy was given to 14 patients and 27 received chemotherapy. Patients with stomach as the primary site had a slightly better outlook than patients with intestinal tumors. In patients with stage I and II disease the group which had been resected and received both radiation treatment and chemotherapy had the best prognosis with a 3-year survival of 76%. The material also indicates that radiotherapy is of value for GI-NHL in stage I or II.
对36例原发性胃肠道非霍奇金淋巴瘤(NHL)患者进行了回顾性研究,其中16例发生在胃,14例发生在小肠,3例发生在回盲部,3例发生在大肠。平均年龄为57岁。根据“工作分类法”,大细胞淋巴瘤最为常见。所有患者均接受了手术探查,27例行切除术,9例行剖腹活检术。14例患者接受了放疗,27例接受了化疗。以胃为原发部位的患者预后略优于肠道肿瘤患者。在Ⅰ期和Ⅱ期疾病患者中,接受了切除手术并同时接受放疗和化疗的组预后最佳,3年生存率为76%。该资料还表明,放疗对Ⅰ期或Ⅱ期胃肠道NHL有价值。